Real-world Ruxolitinib Experience in PV

Not yet recruitingOBSERVATIONAL
Enrollment

153

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Polycythemia Vera
All Listed Sponsors
lead

Gruppo Italiano Malattie EMatologiche dell'Adulto

OTHER

NCT06251102 - Real-world Ruxolitinib Experience in PV | Biotech Hunter | Biotech Hunter